Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanyan Yaogang Biopharmaceutical is a specialized biotechnology company based in Shenyang, China, focusing on the research, development, and manufacturing of peptide-based therapeutics. The company operates as a core entity within the Shenyang Pharmaceutical Port (Yaogang), providing comprehensive CDMO services that include peptide synthesis, process optimization, and advanced formulation development. Their technical expertise is centered on complex peptide sequences and long-acting injectable delivery systems. Yuanyan Yaogang supports both the development of innovative peptide drugs and high-end generic versions of blockbuster metabolic treatments. The company aims to provide scalable manufacturing solutions that bridge the gap between laboratory research and commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanyan Yaogang Biopharmaceutical Shenyang.